New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
OmniSci Recognized by SIIA as Best Big Data Reporting & Analytics Solution
-
Lumos Pharma Announces OraGrowtH212 Trial of LUM-201 in PGHD Is Open for Enrollment
-
Lumos Pharma Announces OraGrowtH212 Trial of LUM-201 in PGHD Is Open for Enrollment
-
Form 3 Bright Health Group Inc. For: Jun 24 Filed by: New Enterprise Associates 15, L.P.
-
Form 3 Monte Rosa Therapeutics, For: Jun 23 Filed by: New Enterprise Associates 17, L.P.
-
Form SC 13D/A Desktop Metal, Inc. Filed by: New Enterprise Associates 15, L.P.
-
NEA Elevates Florence and Makhzoumi to Managing General Partner Roles, Promotes Several to Partner
-
Spiras Health Receives $14MM Series B Funding, Led by NEA
-
Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients
-
Broadly Announces Its Official Launch Into The Auto Collision Repair Sector
-
Health Tech Innovators Strive Health and Outset Medical Collaborate to Reinvent Kidney Care
-
CIT GAP Funds Invests in OxiWear to Support Innovations and Emergency Alerting for Pulmonary Hypertension
-
Topia's Technology Recognized by Relocate Awards and FEM America EMMAs as Positive Momentum Continues Into the Summer
-
Tessera Therapeutics Appoints Industry Leaders Elliott Sigal & Mary Rozenman to Board of Directors
-
Certara, Inc. (CERT) Appoints Dr. Carol Gallagher as New Independent Board Member
-
Certara Appoints Dr. Carol Gallagher as New Independent Board Member
-
Certara Appoints Dr. Carol Gallagher as New Independent Board Member
-
Health Enterprise Partners Completes Recapitalization of AllyAlign Health
-
Form 4 Desktop Metal, Inc. For: Jun 08 Filed by: New Enterprise Associates 15, L.P.
-
CIT GAP Funds Invests in Capango to Simplify Hiring Process for Restaurants and Retail
-
AllyAlign Health Partners with NEA to Accelerate Delivery of First-Class Care for Seniors
-
Pledge 1% Launches Boardroom Allies with Top Venture Capitalists to Unlock Billions in Corporate Philanthropy and Usher in a New Era of Social Impact
-
CIT GAP Funds Invests in Acomhal to Advance Therapies for Cancer Treatment
-
Form SC 13D/A Eargo, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Stablix Therapeutics Launches with $63 Million Series A Financing
-
Topia Awarded U.S. Patent on Exclusive Technology Powering Automated Compliance Management Solution
-
Prove to Acquire Mobile Behavioral Biometrics Company UnifyID to Accelerate Dynamic Multi-Factor Authentication
-
Prove to Acquire Mobile Behavioral Biometrics Company UnifyID to Accelerate Dynamic Multi-Factor Authentication
-
Form 4 Eargo, Inc. For: May 24 Filed by: New Enterprise Associates 15, L.P.
-
Stride Health's Enrollment Platform powers CMS "Gig Workers' Week of Action" with DoorDash, Postmates, Uber, Wonolo and more
-
Woebot Health Receives FDA Breakthrough Device Designation for Postpartum Depression Treatment
-
Topia Launches New Features To Give Businesses the Visibility, Agility & Compliance They Need to Navigate Post-Pandemic World of Work
-
Form 4 Coursera, Inc. For: May 19 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Spokn Brings Podcasting to Work with Funding from NEA, Y Combinator
-
3D printer Formlabs doubles valuation after SoftBank fund-led investment round
-
Lumos Pharma to Participate in the Jefferies Virtual Healthcare Conference
-
Lumos Pharma to Participate in the Jefferies Virtual Healthcare Conference
-
Lumos Pharma to Participate in the Oppenheimer Rare & Orphan Disease Summit
-
Lumos Pharma to Participate in the Oppenheimer Rare & Orphan Disease Summit
-
Large-Scale Study Finds Mental Health App Forms Bond With Users, Marking Key Evolution in Digital Therapeutics
-
Industry Innovator Strive Health Selects Colorado for Headquarters Expansion
-
Aetion Closes $110M Series C Funding Round Led by Warburg Pincus
-
Vori Health Announces $45MM Series A Led By NEA
-
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
-
Lumos Pharma Reports First Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
-
Timescale Raises $40M Series B as Cloud Adoption of Its Database Accelerates
-
AIRINC and Topia Establish Strategic Partnership to Deliver Global Talent Mobility Solutions
-
Goody Launches Goody+ To Allow Individuals and Corporations To Make Mobile Gifting More Personal and as Fun and Easy as Sending a Text
-
Affinia Therapeutics Closes $110 Million Series B Financing
-
CIT GAP Funds Invests in Advanced Aircraft Company to Increase Productivity Among UAS Operators

